ToxSci Advance Access published online on April 11, 2006
Toxicological Sciences, doi:10.1093/toxsci/kfj190
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Biochemistry, The Chinese University of Hong Kong, Shatin, N.T., HONG KONG
* To whom correspondence should be addressed. Estrogen plays a crucial role in the development of breast cancer, and the inhibition of estrogen synthesis has been an important target for the prevention and treatment of this disease. The rate-limiting reaction of the hormone biosynthesis is catalyzed by cytochrome P450 (CYP) 19 enzyme or aromatase. It has been a genuine interest to uncover an aromatase-inhibitory compound from a dietary source. Resveratrol is a polyphenolic compound that can be isolated from grape peel. Because of its structural resemblance to estrogen, resveratrol's agonistic and antagonistic properties on estrogen receptor have been examined and demonstrated. In the present study, the effect of resveratrol on the expression and enzyme activity of aromatase was investigated. By assaying on MCF-7 cells stably transfected with CYP19 (MCF-7aro cells), resveratrol inhibited the aromatase activity with an IC50 value of 25 µM. Kinetic analysis indicated that both competitive and non-competitive inhibition might be involved. The administration of 10 nmol/l testosterone - a substrate of aromatase - produced a 50% increase in MCF-7aro cell number. This cell proliferation specifically induced by testosterone was significantly reduced by 10 µM resveratrol. In addition, 50 µM resveratrol significantly reduced the CYP19-encoding mRNA abundance in SK-BR-3 cells. The transcriptional control of CYP19 gene is tissue-specific, and promoter regions I.3 and II have previously been shown to be responsible for CYP19 expression in breast cancer cells. Luciferase reporter gene assays revealed that resveratrol could repress the transcriptional control dictated by the promoter regulation. The present study illustrated that pharmacological dosage of resveratrol inhibited aromatase at both the enzyme and mRNA levels.
Received January 11, 2006
Accepted April 3, 2006
Carcinogenicity
The Red Wine Polyphenol Resveratrol Displays BI-Level Inhibition on Aromatase in Breast Cancer Cells
Yun Wang 1,
Kai Woo Lee 1,
Franky L. Chan 2,
Shiuan Chen 3,
and
Lai K. Leung 4 *
2 Department of Anatomy, The Chinese University of Hong Kong, Shatin, N.T., HONG KONG
3 Division of Immunology, Beckman Research Institute of the City of Hope, Duarte, CA 91010, U.S.A
4 Department of Biochemistry, The Chinese University of Hong Kong, Shatin, N.T., HONG KONG; Food and Nutritional Sciences Programme, The Chinese University of Hong Kong, Shatin, N.T., HONG KONG
Lai K. Leung, E-mail: laikleung{at}cuhk.edu.hk
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. R. Quesnell, J. Erickson, and B. D. Schultz Apical electrolyte concentration modulates barrier function and tight junction protein localization in bovine mammary epithelium Am J Physiol Cell Physiol, January 1, 2007; 292(1): C305 - C318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rice and S. A Whitehead Phytoestrogens and breast cancer -promoters or protectors? Endocr. Relat. Cancer, December 1, 2006; 13(4): 995 - 1015. [Abstract] [Full Text] [PDF]
|
|